Ademetionine 1,4-butanedisulfonate plus Dexamethasone significantly enhances therapeutic efficacy in cholestatic hepatitis
Ademetionine 1,4-butanedisulfonate plus dexamethasone for cholestatic hepatitis: therapeutic efficacy and risk factors.
Abstract
Ademetionine 1,4-butanedisulfonate (SAMe-BD) combined with Dexamethasone (DEX) significantly enhanced therapeutic efficacy in cholestatic hepatitis patients, improving liver function, inflammation, and fibrosis markers without increasing adverse reactions.
